UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of January 2013

 

Commission File Number: 1-32186

 

YM BIOSCIENCES INC.

 

(Translation of registrant's name into English)

 

Suite 400, Building 11

5045 Orbiter Drive

Mississauga, Ontario

Canada L4W 4Y4

 

(Address of principal executive offices)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F  o Form 40-F x

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1)   o

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7)   o

 

 

 

 
 

 

 

 

DOCUMENTS FILED

 

See the Exhibit Index hereto.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

YM BIOSCIENCES INC.
By: /s/ Leonard Vernon  

Leonard Vernon

Vice President, Finance and Administration

 

Date: January 31, 2013

 

 
 

 

 

 

 

EXHIBIT INDEX

 

Exhibit Description
 99.1 News Release Dated January 31, 2013 - YM BioSciences Shareholders Approve Plan of Arrangement with Gilead Sciences

 

YM Biosciences (AMEX:YMI)
Historical Stock Chart
From Sep 2024 to Oct 2024 Click Here for more YM Biosciences Charts.
YM Biosciences (AMEX:YMI)
Historical Stock Chart
From Oct 2023 to Oct 2024 Click Here for more YM Biosciences Charts.